The pros and cons of corporate stock options have been debated since the incentive was created. Learn more about the basics ...

Here are a few examples. In 2018, the S&P 500 index lost 6% of its value. Yet the Vanguard Utilities ETF gained roughly 4%. Then in 2020, the S&P 500 plunged by 19%. This ETF, however, once again ...

Time to consider buying? appeared first on The Motley Fool UK. Investors who don’t own energy shares need to see this now.

Fund manager Charlie Dreifus breaks down how a huge gulf in valuations between small caps and the market compares with the ...

"The odds that Bitcoin and crypto will become a significantly larger asset class have risen markedly," Charles Morris, an analyst at investment company ByteTree told AFP. Bitcoin reached $75,000 on ...

Trump has made tariffs on China one of his biggest priorities, and Wall Street is bracing for impact. Watch out for these ...

Now that Donald Trump has gone from being a former president to the new president-elect, many are wondering how his electoral ...

Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the drug's first full quarter on the market. A mere year ago, Madrigal had no ...

Retired investors still have numerous options to add to their passive income streak, while rates and yields are still on the ...

US stocks reached record highs after Donald Trump won. Here are eight top places to invest, based on insights from seven ...

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

Boeing reported its third-quarter earnings late last month. The news wasn't great: A 1% decline in sales to $17.8 billion, ...